Stock info Merck & Co | Filter  Basic-Info

Merck KGaA & Co

The company's head quarter is located in Kenilworth. Merck KGaA & Co is mostly active in the pharmaceutical sector. Kenneth C. Frazier is the company' CEO. Robert M. Davis runs the company as a CFO. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

Past year was a negative year for Merck KGaA & Co investors

The stock gained over the past 12 months at around 18 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 63 percent. Merck KGaA & Co's revenues between 2011 and 2015 were very constant and moved between 47,27 billion dollars and 39,5 billion dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 6,39 billion dollars and 4,46 billion dollars.

The American company paid out dividends in the past 5 years. On average the Merck KGaA & Co stock yielded a delivered a dividend yield of around 8,49 percent over the past 5 years. Over the past 5 years Merck KGaA & Co raised her dividends share each year. So because of the yearly raised dividends per share Merck KGaA & Co is a kind of dividend aristocrat.

At the end of 2015 Merck KGaA & Co employed at around 70 thousand people.

Merck KGaA & Co' balance mostly financed with equity

At the end of 2015 the American company's balance sheet was worth 101,78 billion dollars. The total debt of the pharmaceutical company was at the end of 2015 57,1 billion dollars, which equals around 56,1 percent of the total balance sheet. As per the end of 2015 Merck KGaA & Co's price/earnings-ratio equaled 12. So investors paid for 1 stock 12 times the earnings per share of 2015. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 143,9 billion dollars. At the end of 2015 the American company had around 2,78 billion stocks listed on the stock exchange(s).

All Merck KGaA & Co's financial reports are available here. More information about Merck KGaA & Co can be found it's website. .